- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT06551558
Einfluss einer globalen Erwärmungsstrategie des Patienten auf die Prävalenz von Hypothermie im Aufwachraum (REGLO)
Auswirkungen einer Strategie zur globalen Erwärmung, von der Ankunft des Patienten im Operationssaal bis zu seiner Entlassung aus dem Aufwachraum, im Vergleich zu einem empfohlenen Management der intraoperativen Erwärmung auf die Prävalenz von Hypothermie im Aufwachraum
50% of patients are hypothermic when they arrive in the recovery room. This hypothermia is potentially at risk for the patient (increases bleeding, risk of infection, risk of cardiac involvement, morbid mortality) and 33,2% steel hypothermic when they discharge from the recovering room. The anesthesia team must prevent these risks through prevention and treatment measures. Currently the majority of patient warming is done only in the operating room, we want to measure the impact of the extension of this warming before and after the surgery on the patient's temperature and on side effects related to hypothermia.
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
Hypothermia is defined as a core temperature below 36°C. It is classified by severity stage. A temperature below 36°C is mild hypothermia, below 35°C moderate hypothermia and below 34°C severe hypothermia.
The impact of hypothermia on the body is related to decreased metabolic and immune activities. The vasoconstriction induced by hypothermia implies a decrease in vascularization of the organs that can cause tissue damage.
These effects explain the role of hypothermia in the pathophysiology of certain perioperative and postoperative complications in the longer term.
Intraoperative hypothermia is responsible for the increase of:
- 4 times the risk of Surgical Site Infection,
- twice the risk of cardiovascular morbidity, associated with increased mortality,
- 33% of transfusion need,
- 1.5 times the need for continued mechanical ventilation,
- 3 times the duration of recovering room,
- twice the hospital stay. This is why hypothermia is responsible for excess perioperative mortality.
According to a 2019 study (Alfonsi P, Bekka S, Aegerter P, SFAR Research Network investigators. Prevalence of hypothermia on admission to recovery room remains high despite a large use of forced-air warming devices: Findings of a non-randomized observational multicenter and pragmatic study on perioperative hypothermia prevalence in France), the prevalence of hypothermia increases from 16.2% of patients before anesthetic induction to 53.5% of patients admitted to the Recovering room. At the end of Recovering room, 33.2% of patients were hypothermic. Among these patients, 15.2% became hypothermic during the recovering room stay.
The risk factors for perioperative hypothermia are multiple:
Patient-related factors: low body mass index; undernutrition; ASA score > 1; pre-existing conditions altering thermoregulation (ex: diabetes with polyneuropathy, hypothyroidism, consumption of sedative or psychoactive drugs); pre-existing hypothermia at surgery.
Factors related to anesthesia techniques: duration of anesthesia > 2 hours; combined general and neuro-axial anesthesia; administration of large volumes of intravenous solutes or transfusion of non-rewarmed globular units.
Factors related to surgery: type, extent and duration of surgery witch use of large amounts of unheated irrigation fluid.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Poitiers, Frankreich, 86000
- Poitiers University Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Patient undergoing laparoscopic visceral surgery under general anesthesia with transition to recovering room
Exclusion Criteria:
- Patient undergoing urgent surgery.
- Presence of pre-existing infection (temperature higher than 38°C when receiving the patient in the hospital ward.
- Patient with predetermined length of stay in recovering room.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: RéGlo arm
Innovative support with global warming strategy. |
A systematic pre- and post-operative warming associated with the optimization of per-operative warming. |
|
Sonstiges: Control arm
Support according to recommendations |
per-operative warming only thanks to the "Optimized" Forced air blanket with a prewarming of 10 minutes performed in the operating room. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the prevalence of hypothermia at the exit of Interventional for patients who underwent laparoscopic visceral surgery.
Zeitfenster: 1 day
|
Proportion of patients with hypothermia after discharge of recovering room. Hypothermia is defined as a body temperature < 36°C. |
1 day
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the average total mechanical ventilation time
Zeitfenster: 1 day
|
it is the time between intubation and extubation, expressed in minutes. |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the average thermal comfort of preoperative patients, on arrival in the pre- anesthesia room
Zeitfenster: 1 day
|
evaluated by the Likert scale, ranging from 0 for discomfort too cold with strong chills to 4 for discomfort too hot with sweat with optimal comfort to 2 (self-assessment) |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per- operative warming, the average thermal comfort of preoperative patients, on arrival in the recovering room
Zeitfenster: 1 day
|
every 15minutes until discharge, evaluated by the Likert scale, ranging from 0 for discomfort too cold with strong chills to 4 for discomfort too hot with sweat with optimal comfort to 2 (self-assessment). |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the proportion of patients in intraoperative hypothermia
Zeitfenster: 1 day
|
number of patient with body temperature under 36°C between arrival in pre-operative room and discharge of operating room |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 36°C (mild hypothermia)
Zeitfenster: 1 day
|
expressed in minutes. |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 35°C (moderate hypothermia)
Zeitfenster: 1 day
|
expressed in minutes. |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 34°C (severe hypothermia)
Zeitfenster: 1 day
|
expressed in minutes. |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The lowest average temperature reached in °C over the entire management
Zeitfenster: 1 day
|
the lowest temperture between arrival in the pre-anaesthesia room and exit from recovering room |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The proportion of hypothermic patients arriving in recovering room
Zeitfenster: 1 day
|
number of patient with a temperature below 36°C |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average duration of oxygen therapy
Zeitfenster: 1 day
|
calculated from the introduction of oxygen therapy until its withdrawal in post extubation, regardless of the time of implementation or cessation before resumption of treatment (failure to withdraw oxygen therapy will not be considered), expressed in minutes. |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of Nausea or Vomiting Postoperative
Zeitfenster: 1 day
|
number of patient with Nausea or Vomiting in recovering room evaluated every 15 minutes until discharge |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of chills
Zeitfenster: 1 day
|
number of chills during post-operative monitoring by a Likert scale |
1 day
|
|
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of stirring phase presence
Zeitfenster: 1 day
|
number of stirring phase evaluated every 15 minutes until discharge |
1 day
|
|
The average amount of blood loss per operation
Zeitfenster: 1 day
|
blood loss measured from the time of entry into the operating theatre to the exit from the operating theatre expressed in millilitres. |
1 day
|
|
The average of immediate post-operative blood loss
Zeitfenster: 1 day
|
blood loss measured in recovering room expressed in millilitres |
1 day
|
|
The general average of the thermal variation
Zeitfenster: 1 day
|
the difference between the patient's lowest and highest temperature between their arrival in the pre-anaesthesia room and their exit from recovering room, expressed in degrees Celsius |
1 day
|
|
The average of thermal variation in pre operative
Zeitfenster: 1 day
|
the difference between the lowest and highest temperature of the patient between the arrival in the waiting room of the operating room and the arrival in the operating room, expressed in degrees Celsius |
1 day
|
|
The average thermal variation in per operative
Zeitfenster: 1 day
|
the difference between the lowest and highest temperature of the patient between the arrival and exit of the operating room, expressed in degrees Celsius |
1 day
|
|
the average thermal variation in post operative
Zeitfenster: 1 day
|
the difference between the lowest and highest temperature of the patient between arrival in and validation exit criteria of recovering room,expressed in degrees Celsius |
1 day
|
|
The average length of stay in recovering room
Zeitfenster: 1 day
|
difference between the time of arrival in recovering room and the time of obtaining the exit criteria , expressed in minutes. |
1 day
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Matthieu Boisson, Pu-Ph, Poitiers University Hospital
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2023-A02502-43
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .